Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 3rd Quarter - Amendment

ROWE PLASTIC SURGERY

via HART HEALTH STRATEGIES

3rd Quarter (July 1 - Sep 30) · 2025Posted Oct 21, 2025Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ROWE PLASTIC SURGERY
Description: Medical practice
Location: New York · United States of America

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring health care regulations and legislation
LobbyistsROBERT STEPHEN JASAK jd · ANDREW VOGT
Covered position (ANDREW VOGT): Senate HELP Committee

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ROWE PLASTIC SURGERY — Lobbying — Receipts Report